Notably, we observed among the articles included in this study that CBD was able to interact mainly with TRPVS receptors, as in endometrial cancer (TRPV1) [44], glioma (TRPV2 and TRPV4) [6,10], bladder cancer (TRPV2) [49], and myeloma (TRPV) [60]. This evidence concerns the gene TRPV4 and plasma cell myeloma.